Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China flag China · Delayed Price · Currency is CNY
9.09
-0.54 (-5.61%)
Sep 10, 2026, 1:15 PM CST

SHE:002412 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
236.17198.12220.24205.01167.62134.85
Depreciation & Amortization
40.7540.2340.7650.9751.5951.19
Other Amortization
1.11.280.720.720.710.71
Loss (Gain) From Sale of Assets
-0.390.02-0.02--
Asset Writedown & Restructuring Costs
1.83.260.170.2747.5240.96
Loss (Gain) From Sale of Investments
-69.12-8.19-12.05-62.95-92.71-68.3
Provision & Write-off of Bad Debts
00-0.1-0.020.03-0.27
Other Operating Activities
9.218.311.886.683.947.16
Change in Accounts Receivable
2.47-6.37-110.32-61.77-35.8314.34
Change in Inventory
-14.1113.848.1815.23-6.93-19.57
Change in Accounts Payable
-19.99-5.1-18.557.567.9351.92
Change in Other Net Operating Assets
0.82-----
Operating Cash Flow
188.91245.38130.78160.95143.81212.54
Operating Cash Flow Growth
-4.49%87.62%-18.74%11.92%-32.34%29.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-11.61-11.1-11.64-19.48-11.5-229.34
Sale of Property, Plant & Equipment
0.030.0300.350.230.05
Investment in Securities
-41.34-85.6-38.27-64.44-96.07-48.84
Other Investing Activities
5.09-76.9417.7122.0133.85106.49
Investing Cash Flow
-47.83-173.61-42.19-65.55-84.49-172.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-56.0684.38105150131.62
Total Debt Issued
6.0656.0684.38105150131.62
Short-Term Debt Repaid
--83-95-130-161.62-178
Total Debt Repaid
-65-83-95-130-161.62-178
Net Debt Issued (Repaid)
-58.94-26.94-10.62-25-11.62-46.38
Issuance of Common Stock
----1.35-
Common Dividends Paid
-152.17-1.73-2.55-154.67-4.07-6.58
Other Financing Activities
-0.04---0.120.02
Financing Cash Flow
-211.15-28.67-13.17-179.67-14.22-52.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-70.0843.175.42-84.2845.09-13.25

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
177.3234.28119.15141.47132.3-16.8
Free Cash Flow Growth
-4.80%96.63%-15.78%6.93%--
Free Cash Flow Margin
17.62%22.55%11.86%14.80%14.44%-1.88%
Free Cash Flow Per Share
0.350.470.240.280.26-0.03
Levered Free Cash Flow
46.06187.939.581.48-25.9249.24
Unlevered Free Cash Flow
46.47188.9441.183.78-23.4853.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
----0.080.19
Cash Income Tax Paid
148.63171.41192.73174.93104.01102.21
Change in Working Capital
-30.622.36-120.84-39.75-34.8946.24